Immune responses to measles and measles vaccine: Challenges for measles control

Viral Immunology

Volumn 14, Issue 4, 2001, Pages 297-309

  Moss, William J ^a   Polack, Fernando P ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; MEASLES VACCINE;

CHILD HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; MEASLES; MEASLES VIRUS; MOLECULAR MECHANICS; NONHUMAN; REVIEW; TREATMENT OUTCOME; VACCINATION; VIRUS TRANSMISSION;

ANIMALS; HUMANS; IMMUNITY, ACTIVE; MEASLES; MEASLES VACCINE; VACCINATION;

HUMAN IMMUNODEFICIENCY VIRUS; MEASLES VIRUS; RNA VIRUSES;

EID: 0035734298     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/08828240152716556     Document Type: Review

References (100)

1. Reduced childhood mortality following standard measles vaccination at 4-8 months compared to 9-11 months of age
2. Measles vaccination and reduction in child mortality: A community study from Guinea-Bissau
3. Non-specific beneficial effect of measles immunisation: Analysis of mortality studies from developing countries
4. A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal
5. Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure
6. Secondary failure rates of measles vaccines: A metaanalysis of published studies
7. Vaccine-associated measles pneumonitis in an adult with AIDS
8. Increased childhood morbidity after measles is short-term in urban Bangladesh
9. Natural measles causes prolonged suppression of interleukin-12 production
10. Measles virus infection of thymic epitheluim in the SCID-hu mouse leads to thymocyte apoptosis
11. Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains
12. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus
13. Vitamin A supplements and mortality related to measles: A randomised clinical trial
14. Leukocytic response to measles
15. Measles case fatality among the under-fives: A multivariate analysis of risk factors in a rural area of Bangladesh
16. Measles active and passive immunity in a worldwide perspective
17. Serologic response of children to inactivated measles vaccine
18. Global measles control and regional elimination, 1998-1999
19. Measles antibody: Reevaluation of protective titers
20. Measles antibody: Comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus
21. Vitamin A supplementation reduces measles morbidity in young African children: A randomized, placebo-controlled, double-blind trial
22. Vitamin A supplementation enhances specific IgG antibody levels and total lymphocyte numbers while improving morbidity in measles
23. Alternative routes of measles immunization: A review
24. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants
25. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: A randomised trial
26. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy
27. Infection of monocytes during measles
28. Commentary: An unexpected finding that needs confirmation or rejection
29. Measles virus-specific functional antibody responses and viremia during acute measles
30. Comparison of measles virus-specific antibodies with antibody-dependent cellular cytotoxicity and neutralizing functions
31. Measles
32. Modulation of immune system function by measles virus infection: Role of soluble factor and direct infection
33. Altered reactivity to measles virus: Local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines
34. Altered reactivity to measles virus: Atypical measles in children previously immunized with inactivated measles virus vaccines
35. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months
36. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months
37. Child mortality after high-titre measles vaccines: Prospective study in Senegal
38. Differential CD4 T cell activation in measles
39. Pathogenesis of measles virus infection: An hypothesis for altered immune responses
40. Increased mortality after high-titre measles vaccines: Too much of a good thing
41. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses
42. Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus
43. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination
44. Influence of vaccination schedules and host factors on antibody responses following hepatitis B vaccination
45. Cellular immune responses during complicated and uncomplicated measles virus infections of man
46. Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production
47. Differential mortality by measles vaccine titer and sex
48. Measles mortality and vaccine efficacy in rural West Africa
49. The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune responses in infants
50. A randomized, controlled trial of vitamin A in children with severe measles
51. Measles: Immunosuppression, interleukin-12, and complement receptors
52. Mechanism of suppression of cell-mediated immunity by measles virus
53. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children
54. Detection of measles virus mRNA from autopsied human tissues
55. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism
56. The germinal center reaction
57. Routine vaccinations and child survival: Follow up study in Guinea-Bissau, West Africa
58. Immunologic parameters 2 years after high-titer measles immunization in Peruvian children
59. Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes
60. Measles virus infection enhances IL-lb but reduces tumor necrosis factor-a expression in human monocytes
61. Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets
62. Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal
63. Persistence of measles antibody after revaccination
64. Differential antibody responses to rubella virus infection in males and females
65. Implications of the human immunodeficiency virus epidemic for control and eradication of measles
66. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity
67. Atypical xanthem following exposure to natural measles: Eleven cases in children previously inoculated with killed vaccine
68. Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection
69. Measles virus-induced immunosuppression in cotton rats is associated with cell cycle retardation in uninfected lymphocytes
70. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients
71. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: The role of antibody affinity
72. Observations made during the epidemic of measles on the Faroe Islands in the year 1846
73. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction
74. Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles
75. Production of atypical measles in rhesus macaques: Evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody
76. Altered synthesis of interleukin-12, type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles
77. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains
78. High effectiveness of aerosolized chick embryo fibroblast measles vaccine in seven-month-old and older infants
79. No evidence of long-term immunosuppression after high-titer Edmonston-Zagreb measles vaccination in Senegal
80. Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants
81. Vitamin A and immunity to viral, bacterial and protozoan infections
82. Increased long term mortality associated with rash after early measles vaccination in rural Senegal
83. Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus
84. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells
85. Non-specific effects of vaccines in developing countries
86. Measles vaccination of Thai infants by intranasal and subcutaneous route. Possible interference from respiratory infections
87. Suppression of antigen-specific T cell proliferation by measles virus infection: Role of a soluble factor in suppression
88. Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles
89. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies
90. Isolation of measles virus from a naturally-immune asymptomatically re-infected individual
91. Das verhalten der kutanen tuberkulin-reaktion warend der masem
92. Cellular immunity in measles vaccine failure: Demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination
93. Changes in cytokine production after measles virus vaccination: Predominant production of IL-4 suggests induction of a Th2 response
94. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection
95. Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro
96. Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines
97. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa
98. Strategies for reducing global measles mortality
99. Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity